$2.15 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 113 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 155.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | DENDREON CORPnote 2.875% 1/1 | $110,299,000 | +30.6% | 177,383,000 | +55.4% | 5.13% | +28.9% | |
| NXTM | Buy | NXSTAGE MEDICAL INC | $66,157,000 | +18.5% | 5,027,164 | +28.6% | 3.08% | +16.9% |
| Buy | NUVASIVE INCnote 2.750% 7/0 | $62,429,000 | +2.3% | 64,136,000 | +4.9% | 2.90% | +0.9% | |
| ABBV | Buy | ABBVIE INC | $44,954,000 | +76.2% | 1,005,000 | +62.9% | 2.09% | +74.0% |
| THOR | New | THORATEC CORP | $33,225,000 | – | 891,000 | +100.0% | 1.54% | – |
| THC | Buy | TENET HEALTHCARE CORP | $32,458,000 | +72.5% | 788,000 | +93.1% | 1.51% | +70.2% |
| DYAX | Buy | DYAX CORP | $30,408,000 | +1192.9% | 4,432,625 | +552.0% | 1.41% | +1173.9% |
| MYL | New | MYLAN INC | $29,696,000 | – | 778,000 | +100.0% | 1.38% | – |
| CYH | Buy | COMMUNITY HEALTH SYS INC NEW | $29,537,000 | -1.0% | 711,738 | +11.9% | 1.37% | -2.3% |
| MNTA | New | MOMENTA PHARMACEUTICALS INC | $28,893,000 | – | 2,007,886 | +100.0% | 1.34% | – |
| XOMA | Buy | XOMA CORP DEL | $27,374,000 | +528.4% | 6,096,634 | +408.1% | 1.27% | +521.0% |
| XNPT | Buy | XENOPORT INC | $26,162,000 | +29.9% | 4,605,976 | +13.2% | 1.22% | +28.1% |
| ONTX | New | ONCONOVA THERAPEUTICS INC | $25,615,000 | – | 967,696 | +100.0% | 1.19% | – |
| SPPI | Buy | SPECTRUM PHARMACEUTICALS INC | $25,406,000 | +10619.8% | 3,031,750 | +9448.8% | 1.18% | +10645.5% |
| AET | Buy | AETNA INC NEW | $22,599,000 | +1.6% | 353,000 | +0.9% | 1.05% | +0.3% |
| CSU | New | CAPITAL SR LIVING CORP | $22,221,000 | – | 1,050,648 | +100.0% | 1.03% | – |
| RNA | New | PROSENSA HLDG N V | $21,314,000 | – | 3,224,524 | +100.0% | 0.99% | – |
| GMED | New | GLOBUS MED INCcl a | $20,913,000 | – | 1,197,765 | +100.0% | 0.97% | – |
| PTCT | New | PTC THERAPEUTICS INC | $18,134,000 | – | 845,027 | +100.0% | 0.84% | – |
| INSM | Buy | INSMED INC | $14,529,000 | +119.4% | 930,750 | +68.1% | 0.68% | +116.7% |
| QCOR | Buy | QUESTCOR PHARMACEUTICALS INC | $13,558,000 | +2886.3% | 233,767 | +2237.7% | 0.63% | +2904.8% |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDcall | $13,223,000 | – | 350,000 | +100.0% | 0.62% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS | $11,884,000 | – | 1,632,360 | +100.0% | 0.55% | – |
| BLUE | New | BLUEBIRD BIO INC | $11,410,000 | – | 423,224 | +100.0% | 0.53% | – |
| BIOS | New | BIOSCRIP INC | $10,967,000 | – | 1,249,041 | +100.0% | 0.51% | – |
| NSPH | New | NANOSPHERE INC | $10,286,000 | – | 5,143,219 | +100.0% | 0.48% | – |
| VNDA | New | VANDA PHARMACEUTICALS INC | $8,979,000 | – | 820,000 | +100.0% | 0.42% | – |
| ZGNX | Buy | ZOGENIX INC | $8,297,000 | +26.1% | 4,482,646 | +16.5% | 0.39% | +24.5% |
| ATEC | Buy | ALPHATEC HOLDINGS INC | $7,846,000 | +4.2% | 3,982,738 | +8.4% | 0.36% | +2.8% |
| LPDX | Buy | LIPOSCIENCE INC | $6,912,000 | -10.3% | 1,382,350 | +25.4% | 0.32% | -11.6% |
| ANTH | New | ANTHERA PHARMACEUTICALS INC | $6,801,000 | – | 1,691,857 | +100.0% | 0.32% | – |
| OVAS | Buy | OVASCIENCE INC | $6,020,000 | -21.1% | 607,461 | +9.3% | 0.28% | -22.2% |
| MYL | New | MYLAN INCcall | $5,726,000 | – | 150,000 | +100.0% | 0.27% | – |
| NSTG | New | NANOSTRING TECHNOLOGIES INC | $5,463,000 | – | 496,650 | +100.0% | 0.25% | – |
| AIRM | New | AIR METHODS CORPcall | $5,320,000 | – | 125,000 | +100.0% | 0.25% | – |
| SRPT | New | SAREPTA THERAPEUTICS INCput | $4,723,000 | – | 100,000 | +100.0% | 0.22% | – |
| CASM | New | CAS MED SYS INC | $4,288,000 | – | 3,200,000 | +100.0% | 0.20% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $4,223,000 | – | 151,050 | +100.0% | 0.20% | – |
| ESRX | New | EXPRESS SCRIPTS HLDG CO | $4,017,000 | – | 65,000 | +100.0% | 0.19% | – |
| TXMD | New | THERAPEUTICSMD INC | $3,663,000 | – | 1,250,000 | +100.0% | 0.17% | – |
| NVAX | New | NOVAVAX INC | $3,392,000 | – | 1,076,980 | +100.0% | 0.16% | – |
| GEVA | New | SYNAGEVA BIOPHARMA CORP | $3,170,000 | – | 50,000 | +100.0% | 0.15% | – |
| SQNM | New | SEQUENOM INC | $2,630,000 | – | 985,000 | +100.0% | 0.12% | – |
| Buy | AUXILIUM PHARMACEUTICALS INCnote 1.500% 7/1 | $2,583,000 | +77.9% | 2,500,000 | +66.7% | 0.12% | +76.5% | |
| HOLX | Buy | HOLOGIC INC | $1,989,000 | +194.2% | 96,330 | +175.2% | 0.09% | +190.6% |
| GTXI | New | GTX INC DELcall | $1,013,000 | – | 500,000 | +100.0% | 0.05% | – |
| BAX | New | BAXTER INTL INC | $985,000 | – | 15,000 | +100.0% | 0.05% | – |
| ECYT | Buy | ENDOCYTE INC | $672,000 | +84.6% | 50,430 | +82.0% | 0.03% | +82.4% |
| AVNR | New | AVANIR PHARMACEUTICALS INCcl a new | $656,000 | – | 155,000 | +100.0% | 0.03% | – |
| SPHS | New | SOPHIRIS BIO INC | $578,000 | – | 123,585 | +100.0% | 0.03% | – |
| BRKR | New | BRUKER CORP | $434,000 | – | 21,000 | +100.0% | 0.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 33 | Q2 2024 | 3.3% |
| BIOCRYST PHARMACEUTICALS INC | 32 | Q2 2024 | 2.2% |
| MOLINA HEALTHCARE INC | 27 | Q2 2024 | 1.7% |
| BROOKDALE SR LIVING INC | 26 | Q2 2024 | 2.2% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| DECIPHERA PHARMACEUTICALS IN | 24 | Q1 2024 | 2.0% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-09-17 |
| 3 | 2024-09-12 |
| N-PX | 2024-08-29 |
| 13F-HR | 2024-08-14 |
| 4 | 2024-07-17 |
| 4 | 2024-07-15 |
| 4 | 2024-07-11 |
| 4 | 2024-06-14 |
| 4 | 2024-06-03 |
| 13F-HR | 2024-05-15 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.